Abstract:The modern healthcare system faces an unrelenting threat from microorganisms, as evidenced by global outbreaks of new viral diseases, emerging antimicrobial resistance, and the rising incidence of healthcare-associated infections (HAIs). An effective response to these threats requires rapid and accurate diagnostic tests that can identify causative pathogens at the point of care (POC). Such tests could eliminate diagnostic uncertainties, facilitating patient triaging, minimizing the empiric use of antimicrobial drugs, and enabling targeted treatments. Current standard methods, however, often fail to meet the needs of rapid diagnosis in POC settings. Culture-based assays entail long processing times and require specialized laboratory infrastructure; nucleic acid (NA) tests are often limited to centralized hospitals due to assay complexity and high costs. Here we discuss two new POC tests developed in our groups to enable the rapid diagnosis of infection. The first is nanoPCR that takes advantages of core-shell magnetoplasmonic nanoparticles (MPNs): (i) Au shell significantly accelerates thermocycling via volumetric, plasmonic light-to-heat conversion and (ii) a magnetic core enables sensitive in situ fluorescent detection via magnetic clearing. By adopting a Ferris wheel module, the system expedites multisamples in parallel with a minimal setup. When applied to COVID-19 diagnosis, nanoPCR detected SARS-CoV-2 RNA down to 3.2 copy/μL within 17 min. In particular, nanoPCR diagnostics accurately identified COVID-19 cases in clinical samples (n = 150), validating its clinical applicability. The second is a polarization anisotropy diagnostic (PAD) system that exploits the principle of fluorescence polarization (FP) as a detection modality. Fluorescent probes were designed to alter their molecular weight upon recognizing target NAs. This event modulates the probes' tumbling rate (Brownian motion), which leads to changes in FP. The approach is robust against environmental noise and benefits from the ratiometric nature of the signal readout. We applied PAD to detect clinically relevant HAI bacteria (Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus). The PAD assay demonstrated detection sensitivity down to the single bacterium level and determined both drug resistance and virulence status. In summary, these new tests have the potential to become powerful tools for rapid diagnosis in the infectious disease space. They do not require highly skilled personnel or labor-intensive analyses, and the assays are quick and cost-effective. These attributes will make nanoPCR and PAD well-aligned with a POC workflow to aid physicians to initiate prompt and informed patient treatment.

Advances in Nanomaterials and Their Applications in Point of Care (POC) Devices for the Diagnosis of Infectious Diseases.

Carbon Dots: Current Advances in Pathogenic Bacteria Monitoring and Prospect Applications.

Carbon dots: Current advances in pathogenic bacteria monitoring and prospect applications

Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing

Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid

Migration of pancreatic spontaneous dislodgement stent to the appendix

Application of nanotechnology in biosensors for enhancing pathogen detection.

Advancements in magnetic nanoparticle-based biosensors for point-of-care testing

Portable point-of-care diagnostic devices: an updated review

The Future of Nanotechnology-Driven Electrochemical and Electrical Point-of-Care Devices and Diagnostic Tests

Point-of-care diagnostics for infectious diseases: From methods to devices

Increased number of mast cells in the dominant follicle of the cow: relationships among luteal, stromal, and hilar regions.

The point-of-care-testing of nucleic acids by chip, cartridge and paper sensors

Nano-based Theranostic Approaches for Infection Control: Current Status and Perspectives

Evidence-based point-of-care diagnostics: current status and emerging technologies

An evaluation of the development of IT in a college of nursing and midwifery

Development of Integrated Systems for On-Site Infection Detection

Inorganic nanoparticles‐based strategies for the microbial detection in infectious diseases

Recent advances in nanoparticle-based lateral flow immunoassay as a point-of-care diagnostic tool for infectious agents and diseases

Point-of-care biochemical assays using gold nanoparticle-implemented microfluidics.

LAMP-Based Point-of-Care Biosensors for Rapid Pathogen Detection